The global angiographic catheters market size was estimated at USD 1.61 billion in 2026 and is projected to reach USD 2.89 billion by 2033, growing at a CAGR of 7.71% from 2026 to 2033. The market growth is driven by the rising incidence of cardiovascular and peripheral vascular diseases, as well as the increasing reliance on image-guided diagnostic and interventional procedures.
Key Market Trends & Insights
- The North America angiographic catheters market accounted for the largest global revenue share of 48.43% in 2026.
- The U.S. angiographic catheters industry accounted for the largest share of North America in 2026.
- Based on product type, the diagnostic catheters segment held the largest share in 2026.
- Based on application, the coronary segment held the largest share in 2026.
- Based on material, the nylon segment held the largest share in 2026.
- Based on End use, the hospitals segment held the largest share in 2026.
The growing prevalence of coronary artery disease, cerebrovascular events, and peripheral artery disease is significantly increasing pressure on healthcare systems worldwide. Angiographic catheters play a key role in enabling precise vascular imaging, controlled contrast injection, and real-time procedural navigation. Healthcare providers are increasingly favoring minimally invasive diagnostic approaches and catheter-based interventions; consequently, the demand for angiographic catheters continues to rise across coronary, neurovascular, and peripheral endovascular procedures.
Within this broader landscape, the hydrophilic angiographic catheters market is gaining traction, driven by the need for enhanced catheter trackability, reduced friction, and improved navigation through tortuous vascular anatomy. Hydrophilic-coated catheters are increasingly preferred in complex diagnostic and interventional procedures, as they support smoother advancement, reduce procedural time, and lower the risk of vascular trauma.
Market Size & Forecast
- 2026 Market Size: USD 1.61 Billion
- 2033 Projected Market Size: USD 2.89 Billion
- CAGR (2026-2033): 7.71%
- North America: Largest market in 2026
- Asia Pacific: Fastest market in 2026
The growing prevalence of coronary artery disease, cerebrovascular events, and peripheral artery disease is significantly increasing pressure on healthcare systems worldwide. Angiographic catheters play a key role in enabling precise vascular imaging, controlled contrast injection, and real-time procedural navigation. Healthcare providers are increasingly favoring minimally invasive diagnostic approaches and catheter-based interventions; consequently, the demand for angiographic catheters continues to rise across coronary, neurovascular, and peripheral endovascular procedures.
Looking for more specific insights? Customize this report to suite your business needs
Within this broader landscape, the hydrophilic angiographic catheters market is gaining traction, driven by the need for enhanced catheter trackability, reduced friction, and improved navigation through tortuous vascular anatomy. Hydrophilic-coated catheters are increasingly preferred in complex diagnostic and interventional procedures, as they support smoother advancement, reduce procedural time, and lower the risk of vascular trauma.
The increasing prevalence of cardiovascular diseases (CVDs) remains a primary factor driving the growth of the angiographic catheters industry. According to Oxford Academic (January 2026), the global age-standardized prevalence of CVD is estimated at approximately 7,179 cases per 100,000 population, highlighting the persistent global burden of heart-related disorders. In the U.S., the prevalence of CVDs, including heart failure and cardiac arrhythmias, continues to rise, largely due to sedentary lifestyles, obesity, and associated metabolic comorbidities.
As clinicians seek earlier diagnosis and safer, minimally invasive interventions, hydrophilic angiographic catheters are increasingly adopted in both coronary and peripheral angiography. Their lubricious surface facilitates smoother vessel access and catheter manipulation, supporting higher procedural success rates in patients with complex vascular disease.
Moreover, as reported by the American Heart Association (AHA) in January 2026, in the U.S., cardiovascular disease remains a significant public health challenge, with one death occurring approximately every 34 seconds, amounting to nearly 2,500 deaths each day. This high mortality burden highlights the urgent need for timely diagnosis and effective management of vascular conditions such as coronary artery disease and stroke. Angiographic catheters are integral to this effort, as they enable detailed visualization of blood vessels, accurate contrast delivery, and real-time guidance during both diagnostic angiography and interventional procedures. Clinicians seek to detect arterial blockages earlier and intervene using minimally invasive, catheter-based techniques. Still, the persistent and widespread impact of cardiovascular disease continues to drive the clinical reliance on angiographic catheters.
The rising incidence of Peripheral Arterial Disease (PAD) drives the market's growth. According to an article published by Springer Nature Limited in July 2026, PAD affects an estimated 236.62 million people worldwide. It is associated with a substantially elevated risk of severe complications, including limb ischemia, amputation, and mortality. This large and growing patient population drives sustained demand for accurate vascular assessment and timely intervention. In PAD diagnosis and endovascular treatment, the hydrophilic angiographic catheters market benefits from increasing clinical reliance on devices that enable atraumatic navigation of long, calcified, or occluded peripheral vessels. Hydrophilic coatings improve catheter advancement and contrast delivery, particularly in below-the-knee and complex femoropopliteal interventions.
Technological innovation is one of the major factors driving the growth of the angiographic catheters market. For instance, in May 2026, the Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS) in Lucknow, India, introduced an AI-powered intravascular imaging system that combines real-time 3D angio co-registration with advanced imaging for catheter-guided procedures. The technology integrates artificial intelligence algorithms with intravascular optical coherence tomography (OCT) and angiographic imaging to produce high-resolution, 3D reconstructions of arterial plaque and vessel anatomy during angioplasty procedures. This allows clinicians to visualize vessel morphology in three dimensions, rapidly assess plaque characteristics, and tailor contrast injections and catheter positioning with greater precision than traditional imaging alone. Providing AI-driven, real-time procedural guidance and enhanced 3D imaging, the system improves treatment accuracy, optimizes stent selection and deployment, and supports the more effective use of angiographic catheters.
Looking for a report customized to your requirements? Explore our Custom Research Offering
Grand View Research offers
- Focused market intelligence reports on specific geographies or high-growth segments.
- Extended forecast timelines for long-term planning.
- Competitor Benchmarking and Supply Chain Analysis
- Inclusion of regulatory and policy assessments.
- Inclusion of custom data models, KPIs, or applications unique to your business
- Specific high-impact Data Decks and Tables to support effective decision making
And much more…
